Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m
Experimental Physiology · 2026
DOI: 10.1113/ep093003 ↗At a glance
Randomisierte kontrollierte Studie in Experimental Physiology, 2026. Written by Dominic Gilliand and 12 co-authors. Institution: Department of Respiratory Medicine, University Hospital of Zurich, Zurich, Switzerland. Major MEDLINE topics: Altitude, Pulmonary Disease, Chronic Obstructive, Cerebrovascular Circulation, Oxygen Inhalation Therapy. 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: Lunge Zürich, Swiss National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Topics: COPD
Abstract (original language)
We investigated whether nocturnal oxygen therapy improves next‐day cerebrovascular function in lowlanders with chronic obstructive pulmonary disease (COPD) staying at moderate altitude. This randomized, placebo‐controlled single‐blind crossover trial was performed in moderate‐to‐severe COPD patients [forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC)
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Respiratory Medicine, University Hospital of Zurich, Zurich, Switzerland.
- Research Department, Swiss University of Traditional Chinese Medicine, Bad Zurzach, Switzerland.
ORCID profiles: Michael Furian
Funding
- Lunge Zürich
- Swiss National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Cite
APA
Gilliand, D., Latshang, T. D., Aeschbacher, S. S., Huber, F., Flueck, D., Lichtblau, M., Ulrich, S., Hasler, E. D., Scheiwiller, P. M., Müller, J., Ulrich, S., Bloch, K. E., & Furian, M. (2026). Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m. Experimental Physiology. https://doi.org/10.1113/ep093003
Vancouver
Gilliand D, Latshang TD, Aeschbacher SS, Huber F, Flueck D, Lichtblau M, et al. Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m. Experimental Physiology. 2026. doi:10.1113/ep093003
BibTeX
@article{Gilliand2026,
author = {Gilliand, Dominic and Latshang, Tsogyal D and Aeschbacher, Sayaka S and Huber, Fabienne and Flueck, Deborah and Lichtblau, Mona and Ulrich, Stefanie and Hasler, Elisabeth D and Scheiwiller, Philipp M and Müller, Julian and Ulrich, Silvia and Bloch, Konrad E and Furian, Michael},
title = {Effect of moderate altitude and nocturnal oxygen therapy on cerebrovascular function in patients with COPD: A randomized, crossover trial at 2048 m},
journal = {Experimental Physiology},
year = {2026},
doi = {10.1113/ep093003}
}
EUVIMED